Transarterial chemoembolization using drug eluting beads for the treatment of hepatocellular carcinoma: Now and future
Clinical and Molecular Hepatology
;
: 344-348, 2015.
Artigo
em Inglês
| WPRIM
| ID: wpr-52644
ABSTRACT
Transarterial chemoembolization (TACE) using doxorubicin-eluting beads (DEBs) have been introduced as a novel device which ensures more sustained and tumor-selective drug delivery and permanent embolization compared to conventional TACE with lipiodol. Studies highlighting the use of TACE with DEBs for the treatment of hepatocellular carcinoma (HCC) have shown similar or better results compared to conventional TACE with lipiodol. TACE with DEBs is increasingly being performed interchangeably with conventional TACE. This review assessed the characteristics, clinical outcomes and future direction of TACE with DEBs compared to conventional TACE.
Texto completo:
DisponíveL
Índice:
WPRIM (Pacífico Ocidental)
Assunto principal:
Quimioembolização Terapêutica
/
Óleo Etiodado
/
Carcinoma Hepatocelular
/
Stents Farmacológicos
/
Neoplasias Hepáticas
/
Antineoplásicos
Limite:
Humanos
Idioma:
Inglês
Revista:
Clinical and Molecular Hepatology
Ano de publicação:
2015
Tipo de documento:
Artigo
Similares
MEDLINE
...
LILACS
LIS